GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Median PS Value

PharmX Technologies (ASX:PHX) Median PS Value : A$0.02 (As of Jun. 03, 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. PharmX Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.005. PharmX Technologies's 10-Year median PS Ratio is 4. Therefore, the Median PS Value for today is A$0.02.

As of today (2024-06-03), PharmX Technologies's share price is A$0.026. PharmX Technologies's Median PS Value is A$0.02. Therefore, PharmX Technologies's Price to Median PS Value for today is 1.30.

The historical rank and industry rank for PharmX Technologies's Median PS Value or its related term are showing as below:

ASX:PHX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.67   Med: 1.59   Max: 4.67
Current: 1.3

During the past 13 years, the highest Price to Median PS Value of PharmX Technologies was 4.67. The lowest was 0.67. And the median was 1.59.

ASX:PHX's Price-to-Median-PS-Value is ranked worse than
87.97% of 241 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs ASX:PHX: 1.30

PharmX Technologies Median PS Value Historical Data

The historical data trend for PharmX Technologies's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Median PS Value Chart

PharmX Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.03 0.03 0.03 0.02

PharmX Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 - 0.02 -

Competitive Comparison of PharmX Technologies's Median PS Value

For the Health Information Services subindustry, PharmX Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Price-to-Median-PS-Value falls into.



PharmX Technologies Median PS Value Calculation

PharmX Technologies's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.005*4
=0.02

10-Year Median PS Ratio is 4.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PharmX Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies  (ASX:PHX) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

PharmX Technologies's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.026/0.02
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies Median PS Value Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies (ASX:PHX) Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.